n-Lorem Foundation
California City
About n-Lorem Foundation
N-Lorem Foundation uses antisense technology to create individualized treatments for patients with nano-rare diseases. Antisense medicines, also known as antisense oligonucleotides or ASOs, are intended to precisely connect with RNA, preventing the process of generating a protein that causes sickness. This disrupts the course of diseases, from the most uncommon to those that affect millions of people. For nano-rare patients who are amenable to the company's technology, the n-Lorem Foundation provides the infrastructure, resources, and access necessary for them to receive experimental Antisense oligonucleotides (ASOs) without charge.
Company Facts
- Operating status: Active
- Company type: Non-Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Last round: Grant (Sep 2022)
- Website: nlorem.org
- Phone: +1-760-552-7113
Industries & Categories
Health Care, Non Profit, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/n-lorem-foundation-106739 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.